- Home
- SXTC vs MXCT Comparison
SXTC vs MXCT Comparison
Compare SXTC & MXCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SXTC
- MXCT
- Stock Information
- Founded
- SXTC 2005
- MXCT 1999
- Country
- SXTC China
- MXCT United States
- Employees
- SXTC N/A
- MXCT N/A
- Industry
- SXTC Biotechnology: Pharmaceutical Preparations
- MXCT Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- SXTC Health Care
- MXCT Health Care
- Exchange
- SXTC Nasdaq
- MXCT Nasdaq
- Market Cap
- SXTC 184.5M
- MXCT 159.9M
- IPO Year
- SXTC 2019
- MXCT 2021
- Fundamental
- Price
- SXTC $1.36
- MXCT $1.51
- Analyst Decision
- SXTC
- MXCT Buy
- Analyst Count
- SXTC 0
- MXCT 4
- Target Price
- SXTC N/A
- MXCT $7.50
- AVG Volume (30 Days)
- SXTC 25.6K
- MXCT 530.5K
- Earning Date
- SXTC 08-19-2019
- MXCT 11-05-2025
- Dividend Yield
- SXTC N/A
- MXCT N/A
- EPS Growth
- SXTC N/A
- MXCT N/A
- EPS
- SXTC N/A
- MXCT N/A
- Revenue
- SXTC $1,740,907.00
- MXCT $35,754,000.00
- Revenue This Year
- SXTC N/A
- MXCT N/A
- Revenue Next Year
- SXTC N/A
- MXCT $14.72
- P/E Ratio
- SXTC N/A
- MXCT N/A
- Revenue Growth
- SXTC N/A
- MXCT N/A
- 52 Week Low
- SXTC $0.95
- MXCT $1.26
- 52 Week High
- SXTC $7.84
- MXCT $5.20
- Technical
- Relative Strength Index (RSI)
- SXTC 40.70
- MXCT 43.67
- Support Level
- SXTC $1.20
- MXCT $1.60
- Resistance Level
- SXTC $1.43
- MXCT $1.57
- Average True Range (ATR)
- SXTC 0.08
- MXCT 0.10
- MACD
- SXTC -0.00
- MXCT -0.02
- Stochastic Oscillator
- SXTC 53.33
- MXCT 5.41
About SXTC China SXT Pharmaceuticals Inc.
China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.
About MXCT MaxCyte Inc.
MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The Company has one reportable segment, cell engineering technology. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.